Navigation Links
NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
Date:9/19/2007

cted as the lead institution for this new biomedical complex, and look forward to working with our neighboring institutions to forge new and far-reaching collaborations in order to meet the government's mandate to energize and transform clinical and translational science," says Dr. Antonio M. Gotto Jr., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. "Another key benefit of this program will be its role in helping educate the next generation of researchers trained in the complexities of translating research discoveries into clinical trials and ultimately into practice."

Weill Cornell Medical College is already engaged in numerous ongoing multi-institutional collaborations with members of the Clinical and Translational Science Center -- including Cornell University, Memorial Sloan-Kettering Cancer Center, Hospital for Special Surgery and Hunter College.

"The Clinical and Translational Science Center will also take creative approaches to translational research, developing and improving tools for analyzing research data and managing research studies," says Dr. David Hajjar, senior executive vice dean and executive vice provost of Weill Cornell Medical College, dean of the Weill Cornell Graduate School of Medical Sciences, and the Frank H.T. Rhodes Distinguished Professor of Cardiovascular Biology and Genetics. "A new Biomedical Research Building, already under development, at Weill Cornell will eventually serve as the hub for this new effort."

"This is the largest federal grant ever awarded to this Medical College; and what is truly noteworthy is the reality of several public and private, world-class institutions working in teams across disciplines to promote translational research," says Dr. Julianne Imperato-McGinley, the Center's principal investigator and program director. "And, all important innovations will be shared by virtue of our active participation on national CTSA steering committees."

An accomplishe
'/>"/>

Contact: Jonathan Weil
jweil@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
2. Researchers at Cornell University as been reported using research fund by false claims
3. Family Turmoil and Violence Results in Stress-induced Physical Problems in Young, Cornell Psychologist Finds
4. Check if your “Favourite medical web-site” is indulging in Quackey
5. Teens turning to Internet for medical queries
6. Robots craft medical history
7. NBE to conduct test for medical students from abroad
8. Air pollution combined with greater medical needs
9. Indian Nationals with Foreign Medical Degrees can now practice in India
10. Children! Protecting them from medical mistakes
11. More information sought by patients on medical errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... HOUSTON, Nov. 21 The ... marked the beginning of a collaborative effort to...tnership for Breast Cancer Awareness and Research ... the First Lady of the United States, and Vivian F... , Joining M. D. Anderson in the initiative ...
(Date:11/21/2008)... 11.4% Shareholders Intend To Vigorously Protect ... CINCINNATI, Nov. 21 D...ay filed an amendment to their Schedule 13D with t...roup previously filed a 13D disclosing ownership o...ch operates 77 LasikPlus fixed-site laser vision c...
(Date:11/21/2008)... FRANKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstC...oice for medical intervention in treating 88 perce...50 percent of Americans treated for a chronic cond...rug spending and 75 percent of all medical costs. ...hree years by Medco Health Solutions, Inc. (NYSE: ...
(Date:11/21/2008)... Experiments in mice find running increases produ...ov. 21 (HealthDay News) -- In experiments in mice,...oduction of brain stem cells usually seen with agi...able restoration of the brain,s ability to stave o...o restore a neurochemical that is essential for th...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Exercise Keeps the Brain Young 2
...aharlal Institute of Postgraduate Medical College ...//long strike to protest against the government's ...educational institutes. A spokesman of the Associ...ey had submitted a memo to the government to have ...
...ing medicos to immediately call off their 20-day a...resume work within three days. The court - which a...o warned that strong action will be taken if its o... "We direct that all strikes, protests and demonst...
...diabetic nerve damage has shown promising results....of the University of Manchester, when injected int... gene responsible to prevent nerve damage in hands...ositive preclinical results – reported in the jour...
...rally administered Jawaharlal Nehru Institute for ...R) // in Pondicherry today began a 48-hour long st...ducational institutions. A batch of resident doct...inside the campus urging the Centre to review its ...
Other Medicine News:Health News:New Gene Therapy Treats Diabetic Neuropathy 2
(Date:11/21/2008)...re-FirstCall/ -- , - Not for UK Journalists...ducts for Human Use (CHMP) today,announced its po...),(etanercept) as a treatment for children aged 8...e psoriasis. If approved by the European,Commissi...el will become the,first biologic treatment indic...
(Date:11/20/2008)...- Epeius Biotechnologies,announced today the resu...emotherapy-resistant metastatic soft tissue sarcom...hawla, principal investigator, at the CTOS 14th,a..., 2008. Patients received,repeated infusions of R... of,safety and efficacy data showed no major toxi...
(Date:11/20/2008)... New Jersey American Water has lifted the precaut...he following municipalities in Middlesex, Somerset..., , , Dunellen , Edison , ...lainfield , , , , Somerset County ,...er , Green Brook , Hillsborough , ...
(Date:11/20/2008)...PHASE III TRIAL SHOW SIGNIFICANT, DECREASES I...ION, IN, FIBROMYALGIA ...elgium, Nov. 20 /PRNewswire-FirstCall/,-- Jazz Ph...onext Brussels: UCB),announced today positive pre...hase III pivotal clinical trials of sodium oxybate...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 63rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide Inc 22643 13rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide Inc 22643 2Newly Formed Consortium to Combat Medical Fraud Announces National Agenda to Intensify Fight Against Health Care Fraud Goals 3A Collaboration Across I 22640 1Newly Formed Consortium to Combat Medical Fraud Announces National Agenda to Intensify Fight Against Health Care Fraud Goals 3A Collaboration Across I 22640 2Newly Formed Consortium to Combat Medical Fraud Announces National Agenda to Intensify Fight Against Health Care Fraud Goals 3A Collaboration Across I 22640 3SkyeTek to Host Webinar Discussing RFID Based Solution for Medical Sales Processes Automation 22637 1SkyeTek to Host Webinar Discussing RFID Based Solution for Medical Sales Processes Automation 22637 2Frontage Laboratories Completes Acquisition of Advanced Biomedical Research Inc 28ABR 29 6185 1Frontage Laboratories Completes Acquisition of Advanced Biomedical Research Inc 28ABR 29 6185 2Frontage Laboratories Completes Acquisition of Advanced Biomedical Research Inc 28ABR 29 6185 3Frontage Laboratories Completes Acquisition of Advanced Biomedical Research Inc 28ABR 29 6185 4
...CH TRIANGLE PARK, N.C., Mar 8, 2007 (CCNMatthews v...c. (TSX:AHX)(AMEX:ADH), a,biopharmaceutical compan...r development, today announced that Dr. Antonella,... SENDO,Foundation, an investigator in Adherex,s Eu...ll present data today from that study at,the 5th I...
...N, March 8, 2007--Cancer Research UK scientists in...ncer cells. They report,the findings in the Journa... team of scientists from the Beatson Institute for...cancer cells to commit,suicide, significantly slow...The chemical kick started a gene called p73 that b...
Other Medicine Technology:Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 2Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 3Scottish Scientists Test ‘Secret Weapon’ Against,Tumours 2Scottish Scientists Test ‘Secret Weapon’ Against,Tumours 3
Philips SureSigns C1 compact, portable monitor features non-invasive measurement of essential vital signs as well as versatile spot check and continuous monitoring capabilities. The C1, ideal for tra
...oring, the M3 and M4 monitors offer wireless capab...re. M Series monitors are equipped with a Multi-Me...invasive parameters and input for invasive pressur...r extensions offer Mainstream or Microstream® ...
...ients side and in transit., ,IntelliVue MP20 Juni... in a compact package to match the pace and unique...nments, and patient transfer., ,Built on Philips ...Vue MP20 Junior has highly flexible screen configu...
Compact networked patient monitors for flexible care.
Medicine Products: